[In-silico prediction of pharmacokinetic properties]
- PMID: 16272806
- DOI: 10.1248/yakushi.125.853
[In-silico prediction of pharmacokinetic properties]
Abstract
In silico methods for predicting pharmacokinetic properties range from data-based approaches such as quantitative structure-activity relationships (QSARs), similarity searches, and 3-dimensional QSAR, to structure-based methods such as ligand-protein docking and pharmacophore modelling. Data-based modelling approaches are effective for many drug absorption, distribution, metabolism, and excretion (ADME) processes such as passive membrane permeation, where their molecular mechanism is barely delineated. Therefore QSAR approaches have been applied to simulate the relationships between ADME parameters and molecular structure and properties. In the present investigation, we describe the application of the genetic algorithm-combined partial least-squares (GA-PLS) method to QSAR modelling of various ADME properties. By selecting an appropriate set of molecular descriptors automatically using the genetic algorithm, many ADME properties could be well explained by simple molecular descriptors derived from the 2-dimensional chemical structure.
Similar articles
-
Quantitative structure/activity relationship modelling of pharmacokinetic properties using genetic algorithm-combined partial least squares method.J Drug Target. 2006;14(7):496-504. doi: 10.1080/10611860600844895. J Drug Target. 2006. PMID: 17062396
-
QSAR analysis of the inhibition of recombinant CYP 3A4 activity by structurally diverse compounds using a genetic algorithm-combined partial least squares method.Pharm Res. 2003 Sep;20(9):1401-8. doi: 10.1023/a:1025702009611. Pharm Res. 2003. PMID: 14567634
-
Application of in silico approaches to predicting drug--drug interactions.J Pharmacol Toxicol Methods. 2001 Jan-Feb;45(1):65-9. doi: 10.1016/s1056-8719(01)00119-8. J Pharmacol Toxicol Methods. 2001. PMID: 11489666 Review.
-
In silico approaches for predicting ADME properties of drugs.Drug Metab Pharmacokinet. 2004 Oct;19(5):327-38. doi: 10.2133/dmpk.19.327. Drug Metab Pharmacokinet. 2004. PMID: 15548844 Review.
-
Three- and four-dimensional quantitative structure activity relationship analyses of cytochrome P-450 3A4 inhibitors.J Pharmacol Exp Ther. 1999 Jul;290(1):429-38. J Pharmacol Exp Ther. 1999. PMID: 10381809
Cited by
-
Considerations and recent advances in QSAR models for cytochrome P450-mediated drug metabolism prediction.J Comput Aided Mol Des. 2008 Nov;22(11):843-55. doi: 10.1007/s10822-008-9225-4. Epub 2008 Jun 24. J Comput Aided Mol Des. 2008. PMID: 18574695 Review.